Topical Antisepsis May Thwart SSIs in Upper Aerodigestive Tract Reconstruction Preoperative topical antisepsis mucosal preparation associated with 51% fewer infections Apr 28, 2022
Allo-Transplant With Omidubicel Hints at Longer-Term Benefits Too "Viable" option for patients eligible for umbilical cord blood transplantation, investigator says Apr 27, 2022
Promising Data for Allo-Transplant After CAR T-Cell Failure in LBCL Durable responses with no unexpected or prolonged safety issues Apr 27, 2022
Another Link Between Prostate Cancer Hormone Tx and Impaired Cognition Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
Eprenetapopt-Based Combo Impresses in TP53-Mutant AML/MDS 1-year relapse-free survival rate of 60% with maintenance therapy after transplant Apr 25, 2022
Stop Calling It Cancer; AI Gets a Win in Bladder Cancer; Lack of Price Transparency News, features, and commentary about cancer-related issues Apr 22, 2022
What Does It Take to Confirm a Cancer Cluster? Suspicions are raised at a New Jersey high school, but the road ahead is likely a long one Apr 22, 2022
Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx Consistently low PSA levels failed to signal metastasis Apr 18, 2022
Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1 But response rate driven primarily by injected lesions, expert points out Apr 14, 2022
Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer Responses in a majority of patients, evidence of durability with TTX-030, chemoimmunotherapy Apr 14, 2022
BTK Inhibitor Shows Potential in Immune Thrombocytopenia Across doses, 40% of heavily pretreated patients responded to oral rilzabrutinib Apr 13, 2022
Dual Immunotherapy Improves PFS in Melanoma Resistant to Anti-PD-1 Six-month PFS rate more than doubled with nivolumab/ipilimumab versus ipilimumab alone Apr 13, 2022
Boosting Responses to Neoadjuvant Therapy in Resectable NSCLC Multi-drug platform study identifies promising durvalumab-based combinations Apr 12, 2022
Neoadjuvant Nivolumab a 'New Standard' in Lung Cancer "Another quantum leap in lung cancer therapy," expert says Apr 12, 2022
Genetic Score Shows Promise for Honing PSA Precision Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
PARP Inhibitor-Based Triplet Promising in Endometrial Cancer Olaparib/cyclophosphamide/metformin combo appears effective in older, heavily pretreated patients Apr 11, 2022
Longer-Term Sotorasib Data 'Encouraging' in KRAS-Mutated NSCLC Prolonged tumor response seen in 2-year analysis Apr 11, 2022
DCIS Recurrence Often Represents a New Primary Breast Cancer Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
Bispecific Antibody-NK Cell Complex Impresses in Early Hodgkin/NHL Trial Objective responses in 89% of patients with no CRS, neurotoxicity, or graft-versus-host disease Apr 11, 2022
RT Prior to Mastectomy, Reconstruction Shows Promise U.K. study demonstrates low complication rates and good aesthetic results Apr 08, 2022
Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rights Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomy Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
Black Patients More Often Get 'Substandard' Care for GI Cancers Retrospective study finds worse surgical outcomes, lower odds of receiving chemotherapy Apr 04, 2022
Living Donor Transplant Promising for CRC With Liver-Only Metastases In small study, researchers see "encouraging" survival outcomes Mar 30, 2022
Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults Study finds risk was low, but unequal across different products Mar 28, 2022
3D Mammograms Deliver Fewer False-Positive Findings However, half of women will have a false positive with annual screening with DBT Mar 25, 2022
Triplet Induction Regimen Bests Doublet for Nasopharyngeal Carcinoma Three drugs reduced risk of disease failure, but longer follow-up needed to assess OS Mar 25, 2022
Artificial Sweeteners Not So Sweet When It Comes to Cancer Risk Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
Intraperitoneal Carboplatin Boosts PFS in Ovarian Cancer Should the gynecologic oncology community reconsider IP therapy? Mar 22, 2022
It's Official: Minimally Invasive Hysterectomy Not Safer in Cervical Cancer Final analysis of LACC trial confirms earlier findings Mar 21, 2022
Novel Fixed-Dose Immunotherapy Combo Wins FDA Approval Nivolumab plus relatlimab doubled progression-free survival in unresectable melanoma Mar 21, 2022
Lenvatinib Packaging for Endometrial Cancer Tied to $168 Million in Overspending Presenter breaks news at SGO that drug developer commits to overhauling dose reduction program Mar 20, 2022
Selinexor Proves Mettle in Advanced or Recurrent Endometrial Cancer Benefit was greatest among patients with wild-type p53 cancer in SIENDO trial Mar 20, 2022
Novel ADC Promising in Tough-to-Treat Ovarian Cancer Ocular AEs an issue with mirvetuximab in folate receptor alpha-high platinum-resistant disease Mar 20, 2022
Add-on Pembrolizumab Tied to Good QoL in Women With Advanced Cervical Cancer PRO-based analysis of KEYNOTE-826 trial shows favorable benefit-risk ratio Mar 19, 2022
Adjuvant Chemo Disappoints in Low-Grade Serous Ovarian Cancer Study suggests no improvement in overall survival Mar 19, 2022
Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer Nodal metastasis detected more often than by clinical exam, worrisome false-positive rate Mar 18, 2022
FDA OKs PARP Inhibitor as Adjuvant Therapy in Early Breast Cancer Olaparib (Lynparza) approved for high-risk patients with germline BRCA mutations Mar 14, 2022
Fluorescence-Guided Lumpectomy Shows Promise Imaging system reduced the need for re-excision in one-fifth of patients Mar 11, 2022
